metastasis
Natera Enrolls First Patients in HEROES Metastatic HER2+ Breast Cancer Trial
Natera's Signatera test and diagnostic imaging will be used to monitor patients for progression-free survival over the course of one year.
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
Experts noted, however, there is insufficient evidence to determine which commercially available KRAS G12C inhibitor is the best treatment for brain metastases.
NGS Tumor Testing Gaps Persist in Metastatic Prostate, Urothelial Cancers
A retrospective health record analysis revealed an inconsistent rise in rates of next-generation sequencing testing in metastatic prostate cancer and advanced urothelial cancer.
New Lung Cancer Evolution, Treatment Response Patterns Emerge From TRACERx Study
TRACERx researchers reported on non-small cell lung cancer features linked to disease progression, recurrence, treatment response, and more in seven new papers.